focus -WSS

focus

author：comprehensive 2025-09-30 23:40:19 - browse：97

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A letter from the executive editor: The 2023 STATUS List

WSS

Canadians with cystic fibrosis outlive Americans by a decade

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Study says nonprofit hospitals fall short in charity care spending

Vertex Pharmaceuticals may move headquarters in Boston

'Screen and refer' systems are hurting patients

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

leisure time

focus

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT wants to know your pick for a great summer read or listen

Medical leaders decry Supreme Court decision on affirmative action

Undocumented workers face uncertainty as immigration law takes effect in Florida

DIEP, the 'gold standard' of breast reconstruction, is under threat

The biotech scorecard for Q3: 15 stock

New air purifier tech could be key to improving indoor air quality

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

How to save PrEP access — and even expand it

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Wikipedia

Undocumented workers face uncertainty as immigration law takes effect in Florida

What affirmative action's end means to a medical student

FDA's naming rule on biosimilars has undermined competition

Vertex Pharmaceuticals may move headquarters in Boston

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

knowledge

entertainment

explore

entertainment